Where does Chainalysis, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Chainalysis, Inc. ranks #24,083 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Chainalysis, Inc. hold?

Chainalysis, Inc. holds 11 US utility patents granted between 2024 and 2024, spanning 1 technology areas.

What is Chainalysis, Inc.'s Innovation Score?

Chainalysis, Inc. has an Innovation Score of 33.6 out of 100 (45th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Chainalysis, Inc. focus on?

Chainalysis, Inc.'s top technology area is H04L (Transmission OF Digital Information, e.g. Telegraphic Communication) with 1 patents, ranking #7,285 of 8,956 assignees active in that subclass. Grants appear in 1 CPC subclasses total.

Is Chainalysis, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Chainalysis, Inc..

What does claim depth mean for Chainalysis, Inc.'s patents?

Chainalysis, Inc.'s patents average 2.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Chainalysis, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Chainalysis, Inc.

USPTO PatentsView assignee record - 11 granted patents across 1 technology areas, recorded in grant years 2024–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04L (Transmission OF Digital Information, e.g. Telegraphic Communication).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Chainalysis ranks #24,083 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 1 technology areas.

#24,083
of 49,997 US assignees by volume: 45th percentile
by Innovation Score (33.6/100): 2.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R24083 · US Corporation #24,083 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #24,083/49,997
PHOTO-FINISH Cellview Imaging
CPC-NARROW H04L · 1 areas
INNOV-THIN 33.6/100
CLAIMS-SPARSE 2.5 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2024–2024 · 1y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Cellview Imaging Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Chainalysis’s 33.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (26%) Velocity 20.0 pts (60%) Breadth 3.5 pts (10%) Claim depth 1.5 pts (4%)

Qualcomm Incorporated · highest

85
Medallion Instrument… · near

34
Skyworks Panasonic… · near

34
Chainalysis · this assignee

34
Intact Vascular · near

34
SMR Inventec · near

34
3D Lighting… · lowest

7

What this shows Chainalysis's Innovation Score is 33.6/100 (45th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Chainalysis?

Each dot is one of Chainalysis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Chainalysis’s own 2.5 claims/patent is at or below the 15.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Chainalysis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Chainalysis's grants concentrate

Chainalysis, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 9.1% of grants classified under H04L (Transmission OF Digital Information, e.g. Telegraphic Communication). By volume, Chainalysis sits between Cellview Imaging Inc. and Chenguang Biotech Group Co., Ltd..

Chainalysis's three-year grant acceleration

Chainalysis, Inc. shows 11 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cellview Imaging

11
Centera Photonics

11
Ceramic Data Solu…

11
Certainteed Canada

11
Changchun Meihe S…

11
Chargerback

11
Chemometec A/S

11
Chenguang Biotech…

11
Chainalysis ◀

11

What this shows Chainalysis holds 11 patents at rank #24,127, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Chainalysis

By rank, the assignees closest to #24,127 in granted patent volume.

Leaders in H04L (Transmission OF Digital Information)

Other assignees with the most granted patents in Chainalysis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Chainalysis, neither rank-band nor same-CPC leaders (those blocks stay above). In H04L (Transmission OF Digital Information), Chainalysis ranks #7,285 of 8,956 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (34 here).

SMR Inventec, LLC 34 Intact Vascular, Inc. 34 Medallion Instrumentation Systems, LLC 34 Skyworks Panasonic Filter Solutions Japan Co., Ltd. 34

Chainalysis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 45th percentile higher than 45% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

Chainalysis, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	11	100.0%

Which technologies does Chainalysis, Inc. patent most?

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

Top 1 of 1 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Chainalysis, Inc.'s patent record in context - here's where to go next.

Chainalysis, Inc.'s lead technology class is H04L (Transmission OF Digital Information, e.g. Telegraphic Communication), 9.1% of its portfolio - see every assignee active in that class. Explore H04L
Ranked #24,083 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Chainalysis, Inc. against Cellview Imaging Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.